BioNxt Solutions Inc. BNXTF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.63M | -6.74M | -5.02M | -4.41M | -4.32M |
| Total Depreciation and Amortization | 8.50K | 12.90K | 8.00K | 21.10K | 34.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.86M | 3.68M | 2.00M | 1.59M | 1.65M |
| Change in Net Operating Assets | -533.80K | -189.10K | -707.90K | -916.80K | 228.00K |
| Cash from Operations | -3.30M | -3.23M | -3.72M | -3.71M | -2.41M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 103.40K | 90.70K | 97.30K | 94.60K | 59.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.30K | -36.30K | -36.30K | -36.30K | -- |
| Cash from Investing | 67.10K | 54.40K | 61.00K | 58.30K | 59.30K |
| Total Debt Issued | 1.25M | 1.25M | 4.64M | 6.75M | 5.50M |
| Total Debt Repaid | 0.00 | 0.00 | -1.71M | -2.74M | -2.74M |
| Issuance of Common Stock | 4.64M | 2.94M | 2.60M | 2.06M | 704.40K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -235.00K | -115.00K | -403.80K | -581.90K | -466.90K |
| Cash from Financing | 4.10M | 2.95M | 3.67M | 3.93M | 2.12M |
| Foreign Exchange rate Adjustments | 800.00 | 500.00 | 1.20K | 1.10K | 1.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 869.20K | -225.60K | 12.70K | 275.20K | -230.40K |